Syantra Secures $4.9 Million in Series A-1 Funding; Adds Dr. Rick Mangat to Board of Directors

Syantra, Inc. secures new funding for expansion and commercialization of its pioneering platform for early detection of cancer CALGARY, AB, Sept. 11, 2024 /PRNewswire/ – Syantra, Inc., a privately held precision biotechnology company pioneering a platform to change the way cancer is…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.